VCYT
Veracyte, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth +6.7% ·
share flow +3.6% ·
net new positions +6.2%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 119 | +4 | 67.58M | $3.96B | +10 | −6 |
| Q1 2026 | 118 | +6 | 67.37M | $2.17B | +10 | −4 |
| Q4 2025 | 112 | 0 | 69.04M | $2.91B | +2 | −2 |
| Q3 2025 | 18 | -2 | 46.98M | $1.61B | — | −3 |
| Q2 2025 | 18 | 0 | 39.06M | $1.06B | +1 | −1 |
| Q1 2025 | 15 | -1 | 15.53M | $460.45M | — | −1 |
| Q4 2024 | 16 | +1 | 17.75M | $702.81M | +1 | — |
| Q3 2024 | 14 | +1 | 14.22M | $484.20M | +3 | −2 |
| Q2 2024 | 13 | — | 18.04M | $390.85M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 4.20M | -14.6% | $166.48M | 1.4% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.08M | -3.5% | $161.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.08M | -3.5% | $161.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.08M | -3.5% | $161.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.08M | -3.5% | $161.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.08M | -3.5% | $161.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passive) | 2.91M | — | $115.26M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passive) | 1.84M | -0.3% | $72.88M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 1.84M | -0.3% | $72.88M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Marshall Wace ✦ | 956.58K | +768.9% | $37.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 956.58K | +768.9% | $37.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 845.72K | -3.6% | $33.49M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 635.11K | +134.1% | $25.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 600.70K | +1.1% | $23.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 523.16K | New | $20.72M | 0.1% | New | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 296.20K | -40.8% | $11.73M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 240.21K | -28.4% | $9.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 230.30K | +21.0% | $9.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 230.30K | +21.0% | $9.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 230.30K | +21.0% | $9.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Norges Bank ✦ (passive) | 225.60K | +20.0% | $8.93M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 86.18K | -9.3% | $3.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 48.41K | +3.9% | $1.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 20.06K | +21.5% | $794,257 | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $20.72M | 0.1% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 333 holders, 87.61M shares, $2.75B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.